Paolo Bonfanti

About Paolo Bonfanti

Paolo Bonfanti, With an exceptional h-index of 52 and a recent h-index of 41 (since 2020), a distinguished researcher at Università degli Studi di Milano-Bicocca, specializes in the field of Infectious Diseases, HIV/AIDS, Antibiotic resistance.

His recent articles reflect a diverse array of research interests and contributions to the field:

Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy

Determinants of worse liver‐related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort

Extraction of stylet‐driven pacing lead for left bundle branch area pacing

Mpox Virus in the Pharynx of Men Having Sex with Men: A Case Series

It is time to rethink the approach to cardiovascular risk in people with HIV.

Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study

Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy

Screening for Latent Tuberculosis Infection in People Living with HIV: TUBHIVIT Project, a Multicentre Italian Study

Paolo Bonfanti Information

University

Position

___

Citations(all)

16100

Citations(since 2020)

13372

Cited By

5753

hIndex(all)

52

hIndex(since 2020)

41

i10Index(all)

147

i10Index(since 2020)

102

Email

University Profile Page

Google Scholar

Paolo Bonfanti Skills & Research Interests

Infectious Diseases

HIV/AIDS

Antibiotic resistance

Top articles of Paolo Bonfanti

Determinants of worse liver‐related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort

Liver International

2024/2

Extraction of stylet‐driven pacing lead for left bundle branch area pacing

Journal of Arrhythmia

2024/2

Paolo Bonfanti
Paolo Bonfanti

H-Index: 27

Mpox Virus in the Pharynx of Men Having Sex with Men: A Case Series

Pathogens

2024/1/20

Paolo Bonfanti
Paolo Bonfanti

H-Index: 27

It is time to rethink the approach to cardiovascular risk in people with HIV.

JOURNAL OF HIV AND AGEING

2024

Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study

Internal and Emergency Medicine

2024/1

Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy

Travel Medicine and Infectious Disease

2024/5/1

Screening for Latent Tuberculosis Infection in People Living with HIV: TUBHIVIT Project, a Multicentre Italian Study

2024/4/26

Giuseppe Nunnari
Giuseppe Nunnari

H-Index: 12

Paolo Bonfanti
Paolo Bonfanti

H-Index: 27

Anti-spike antibody level is associated with the risk of clinical progression among subjects hospitalized with COVID-19 pneumonia: results from a retrospective cohort study

Infection

2024/4/23

Paolo Bonfanti
Paolo Bonfanti

H-Index: 27

Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA Study

Viruses

2024/4/15

People with HIV pioneers of injectable cabotegravir and rilpivirine long acting in Italy: who are they?

AIDS

2024/3/1

Early prone positioning does not improve the outcome of patients with mild pneumonia due to SARS-CoV-2: results from an open-label randomised controlled trial–the EPCoT study

ERJ Open Research

2023/7/1

Paolo Bonfanti
Paolo Bonfanti

H-Index: 27

Central nervous system and neuropsychiatric disturbances in people living with HIV

2023

Paolo Bonfanti
Paolo Bonfanti

H-Index: 27

L’ecocardiografia in telemedicina: una possibile soluzione per il contenimento delle liste d’attesa in cardiologia

G. Ital. Cardiol

2023

Paolo Bonfanti
Paolo Bonfanti

H-Index: 27

Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID …

JOURNAL OF HIV AND AGEING

2023

Anti-S-Rbd Titer and Risk of Clinical Progression in Patients with Covid-19 Pneumonia

Topics in Antiviral Medicine

2023

One Health and Global Health: il nuovo lessico delle malattie infettive [One Health and Global Health: the new lexicon of infectious diseases]

JOURNAL OF HIV AND AGEING

2023

Infezione disseminata da Mycobacterium avium complex con batteriemia persistente in un paziente AIDS-presenter [Disseminated Mycobacterium avium complex infection with …

JOURNAL OF HIV AND AGEING

2023

Paolo Bonfanti
Paolo Bonfanti

H-Index: 27

Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort

Liver International

2023/10

GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial

Cell Reports Medicine

2023/6/20

See List of Professors in Paolo Bonfanti University(Università degli Studi di Milano-Bicocca)